Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hinfp
|
ENSMUSG00000032119.4 | histone H4 transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_44305202_44306143 | Hinfp | 1 | 0.924136 | 0.72 | 6.4e-10 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_127508848_127510720 | 27.61 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr17_47909349_47909983 | 20.98 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr11_74837693_74838808 | 13.19 |
Mnt |
max binding protein |
782 |
0.52 |
chr19_41835767_41836202 | 12.10 |
Frat1 |
frequently rearranged in advanced T cell lymphomas |
6014 |
0.15 |
chr11_87358280_87359463 | 11.83 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
152 |
0.93 |
chr8_70698268_70700333 | 11.24 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr7_16815354_16816404 | 11.14 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr15_101976894_101977736 | 10.63 |
Krt78 |
keratin 78 |
23028 |
0.09 |
chr3_103171228_103172264 | 10.49 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr5_108694436_108695224 | 10.38 |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
328 |
0.81 |
chr4_88937840_88939002 | 10.13 |
Gm49890 |
predicted gene, 49890 |
100 |
0.95 |
chr17_34836344_34837687 | 10.01 |
Dxo |
decapping exoribonuclease |
4 |
0.52 |
chr11_102316544_102317735 | 9.87 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr1_77298255_77298528 | 9.57 |
Epha4 |
Eph receptor A4 |
79216 |
0.11 |
chr5_147894219_147894411 | 9.46 |
Slc46a3 |
solute carrier family 46, member 3 |
500 |
0.77 |
chr7_27232781_27233338 | 9.23 |
Coq8b |
coenzyme Q8B |
36 |
0.93 |
chr2_91636356_91636536 | 9.20 |
F2 |
coagulation factor II |
32 |
0.96 |
chr3_95314674_95315950 | 9.15 |
Cers2 |
ceramide synthase 2 |
45 |
0.67 |
chr16_47171877_47172095 | 9.10 |
Gm18169 |
predicted gene, 18169 |
40384 |
0.21 |
chr5_142920749_142921092 | 9.08 |
Actb |
actin, beta |
14166 |
0.14 |
chr13_23533504_23534327 | 9.02 |
H2ac10 |
H2A clustered histone 10 |
9 |
0.78 |
chr8_70609185_70610414 | 8.90 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr3_10243757_10243938 | 8.90 |
1700029B24Rik |
RIKEN cDNA 1700029B24 gene |
2035 |
0.18 |
chr18_5390246_5390643 | 8.87 |
Gm50065 |
predicted gene, 50065 |
19962 |
0.19 |
chr17_39844374_39844569 | 8.78 |
CT010467.1 |
18s RNA, related sequence 5 |
1882 |
0.31 |
chr1_9780503_9780709 | 8.73 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
3172 |
0.18 |
chr9_61370339_61371660 | 8.70 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr17_84305198_84305366 | 8.62 |
Thada |
thyroid adenoma associated |
8397 |
0.2 |
chr2_153161013_153161878 | 8.59 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr4_106804255_106804459 | 8.57 |
Acot11 |
acyl-CoA thioesterase 11 |
641 |
0.69 |
chr18_35848127_35849279 | 8.49 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr7_100466963_100467472 | 8.38 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr5_109557850_109558797 | 8.27 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr17_63261600_63261762 | 8.23 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
51290 |
0.13 |
chr3_10302605_10302783 | 8.19 |
Fabp12 |
fatty acid binding protein 12 |
1511 |
0.22 |
chr17_46030764_46031738 | 8.11 |
Vegfa |
vascular endothelial growth factor A |
105 |
0.96 |
chr7_5060805_5061447 | 8.10 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr4_44167348_44167756 | 8.04 |
Rnf38 |
ring finger protein 38 |
17 |
0.98 |
chr13_112746381_112746563 | 8.04 |
Slc38a9 |
solute carrier family 38, member 9 |
10862 |
0.15 |
chr4_148204076_148204384 | 8.01 |
Fbxo2 |
F-box protein 2 |
43609 |
0.08 |
chr10_111168255_111168422 | 7.99 |
Osbpl8 |
oxysterol binding protein-like 8 |
3536 |
0.18 |
chr14_25606696_25608421 | 7.96 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr5_129501148_129501544 | 7.94 |
Sfswap |
splicing factor SWAP |
95 |
0.8 |
chr11_109550376_109550622 | 7.83 |
Arsg |
arylsulfatase G |
6745 |
0.17 |
chr6_120556312_120556482 | 7.78 |
1700072O05Rik |
RIKEN cDNA 1700072O05 gene |
1601 |
0.27 |
chr15_79774094_79774687 | 7.76 |
Dnal4 |
dynein, axonemal, light chain 4 |
7 |
0.95 |
chr12_110844856_110845029 | 7.71 |
Gm26912 |
predicted gene, 26912 |
274 |
0.81 |
chr9_64533581_64533938 | 7.67 |
Megf11 |
multiple EGF-like-domains 11 |
13140 |
0.25 |
chr11_78074361_78074827 | 7.67 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chrX_94366585_94367598 | 7.65 |
Apoo |
apolipoprotein O |
26 |
0.81 |
chr5_36726254_36726643 | 7.64 |
Gm43701 |
predicted gene 43701 |
22170 |
0.11 |
chr6_88758585_88758947 | 7.61 |
Gm43999 |
predicted gene, 43999 |
16039 |
0.11 |
chr17_69417733_69418106 | 7.59 |
C030034I22Rik |
RIKEN cDNA C030034I22 gene |
458 |
0.76 |
chr9_55149537_55150132 | 7.59 |
Ube2q2 |
ubiquitin-conjugating enzyme E2Q family member 2 |
249 |
0.92 |
chr4_154122202_154122744 | 7.53 |
Trp73 |
transformation related protein 73 |
5868 |
0.12 |
chr9_44767080_44767695 | 7.46 |
Arcn1 |
archain 1 |
411 |
0.47 |
chr19_17323425_17323682 | 7.31 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
11883 |
0.21 |
chr8_94186589_94186942 | 7.30 |
Gm39228 |
predicted gene, 39228 |
3476 |
0.12 |
chr5_100567324_100567596 | 7.28 |
Plac8 |
placenta-specific 8 |
4037 |
0.16 |
chr8_124658487_124658754 | 7.26 |
2310022B05Rik |
RIKEN cDNA 2310022B05 gene |
4749 |
0.18 |
chr2_128174695_128174861 | 7.25 |
Gm14009 |
predicted gene 14009 |
15209 |
0.2 |
chr19_42128418_42129450 | 7.17 |
Avpi1 |
arginine vasopressin-induced 1 |
55 |
0.96 |
chr6_72389445_72389953 | 7.16 |
Vamp8 |
vesicle-associated membrane protein 8 |
212 |
0.87 |
chr10_69352241_69353323 | 7.08 |
Cdk1 |
cyclin-dependent kinase 1 |
121 |
0.96 |
chr2_69897352_69898558 | 7.06 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
652 |
0.6 |
chr4_72200825_72201688 | 7.05 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
92 |
0.8 |
chr19_46304500_46305228 | 7.04 |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
64 |
0.9 |
chr2_170130477_170131578 | 7.03 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr12_16580685_16580927 | 7.02 |
Lpin1 |
lipin 1 |
8914 |
0.24 |
chr11_94321426_94321816 | 6.97 |
Luc7l3 |
LUC7-like 3 (S. cerevisiae) |
274 |
0.88 |
chr2_174329445_174331091 | 6.90 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr3_105686913_105687657 | 6.82 |
Ddx20 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
159 |
0.93 |
chr9_7829609_7829777 | 6.81 |
Birc2 |
baculoviral IAP repeat-containing 2 |
5562 |
0.18 |
chr2_34870006_34870166 | 6.79 |
Psmd5 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 |
847 |
0.45 |
chr3_14886091_14887033 | 6.79 |
Car2 |
carbonic anhydrase 2 |
77 |
0.97 |
chr11_120303609_120303922 | 6.75 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
13972 |
0.09 |
chr15_83344016_83344590 | 6.70 |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
5871 |
0.16 |
chr11_115419815_115420841 | 6.70 |
Kctd2 |
potassium channel tetramerisation domain containing 2 |
16 |
0.83 |
chr14_76882933_76883168 | 6.70 |
Gm48969 |
predicted gene, 48969 |
21479 |
0.19 |
chr2_29788160_29788352 | 6.69 |
Coq4 |
coenzyme Q4 |
3 |
0.76 |
chr16_78307886_78308098 | 6.69 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
5505 |
0.17 |
chr15_81585272_81586453 | 6.69 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr3_14878006_14878215 | 6.68 |
Car2 |
carbonic anhydrase 2 |
8163 |
0.19 |
chr16_20717040_20718151 | 6.67 |
Polr2h |
polymerase (RNA) II (DNA directed) polypeptide H |
70 |
0.6 |
chr16_35856803_35857099 | 6.60 |
Gm49730 |
predicted gene, 49730 |
11000 |
0.11 |
chr6_17743426_17743670 | 6.56 |
St7 |
suppression of tumorigenicity 7 |
44 |
0.97 |
chr5_106964155_106965054 | 6.56 |
Cdc7 |
cell division cycle 7 (S. cerevisiae) |
43 |
0.98 |
chr17_34898151_34899707 | 6.55 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr12_59131240_59132031 | 6.55 |
Mia2 |
MIA SH3 domain ER export factor 2 |
133 |
0.94 |
chr14_117674551_117674852 | 6.55 |
Mir6239 |
microRNA 6239 |
279146 |
0.01 |
chr6_124740514_124741215 | 6.54 |
Grcc10 |
gene rich cluster, C10 gene |
149 |
0.71 |
chr4_133874309_133874475 | 6.53 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
339 |
0.79 |
chr6_136518537_136519196 | 6.48 |
Atf7ip |
activating transcription factor 7 interacting protein |
20 |
0.67 |
chr7_115844532_115844833 | 6.47 |
Sox6 |
SRY (sex determining region Y)-box 6 |
1423 |
0.56 |
chr6_83312515_83312842 | 6.45 |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
273 |
0.85 |
chr10_39432725_39432913 | 6.41 |
Gm6963 |
predicted gene 6963 |
7823 |
0.21 |
chr8_105323220_105323493 | 6.36 |
Lrrc29 |
leucine rich repeat containing 29 |
2903 |
0.08 |
chr3_108562098_108562631 | 6.34 |
Tmem167b |
transmembrane protein 167B |
102 |
0.92 |
chr16_91417099_91417268 | 6.33 |
Il10rb |
interleukin 10 receptor, beta |
10739 |
0.1 |
chr8_11055553_11055917 | 6.32 |
9530052E02Rik |
RIKEN cDNA 9530052E02 gene |
6157 |
0.16 |
chr8_83585335_83585534 | 6.32 |
Gm45823 |
predicted gene 45823 |
91 |
0.93 |
chr4_133967146_133967733 | 6.31 |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
2 |
0.97 |
chr11_120624391_120624572 | 6.27 |
Mir6936 |
microRNA 6936 |
395 |
0.42 |
chr5_134313726_134314672 | 6.25 |
Gtf2i |
general transcription factor II I |
179 |
0.92 |
chr3_87982739_87983555 | 6.23 |
Bcan |
brevican |
11308 |
0.09 |
chrX_75416276_75416747 | 6.21 |
Mtcp1 |
mature T cell proliferation 1 |
32 |
0.38 |
chr11_60776763_60777159 | 6.20 |
Top3a |
topoisomerase (DNA) III alpha |
303 |
0.62 |
chr7_48880950_48881793 | 6.19 |
Gm2788 |
predicted gene 2788 |
71 |
0.71 |
chr8_119575060_119575630 | 6.16 |
Dnaaf1 |
dynein, axonemal assembly factor 1 |
110 |
0.57 |
chr14_75845640_75845894 | 6.16 |
Tpt1 |
tumor protein, translationally-controlled 1 |
133 |
0.89 |
chr17_63973867_63974125 | 6.13 |
Fer |
fer (fms/fps related) protein kinase |
36024 |
0.22 |
chrX_48343022_48344334 | 6.13 |
Bcorl1 |
BCL6 co-repressor-like 1 |
92 |
0.97 |
chr8_120540386_120540704 | 6.13 |
Mir7687 |
microRNA 7687 |
1849 |
0.2 |
chr4_9706430_9706608 | 6.12 |
Gm24152 |
predicted gene, 24152 |
10712 |
0.2 |
chr7_120884840_120885014 | 6.10 |
Eef2k |
eukaryotic elongation factor-2 kinase |
2997 |
0.17 |
chr6_143751347_143751526 | 6.09 |
1700060C16Rik |
RIKEN cDNA 1700060C16 gene |
100148 |
0.08 |
chr2_152122973_152123233 | 6.08 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
17579 |
0.13 |
chr19_55284094_55284395 | 6.06 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
90 |
0.97 |
chr5_116021452_116021603 | 6.06 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
119 |
0.94 |
chr1_4785042_4785900 | 6.04 |
Mrpl15 |
mitochondrial ribosomal protein L15 |
221 |
0.88 |
chr7_28925406_28925715 | 6.03 |
Actn4 |
actinin alpha 4 |
6339 |
0.11 |
chr8_107292888_107294249 | 6.03 |
Nfat5 |
nuclear factor of activated T cells 5 |
9 |
0.98 |
chr5_30155166_30155348 | 6.02 |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
1 |
0.57 |
chr7_24377117_24377824 | 5.99 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
4700 |
0.1 |
chr11_78071743_78072223 | 5.98 |
Mir144 |
microRNA 144 |
1022 |
0.22 |
chr2_6263938_6264314 | 5.98 |
Gm13383 |
predicted gene 13383 |
6860 |
0.19 |
chr9_64045641_64045837 | 5.97 |
Gm25606 |
predicted gene, 25606 |
2757 |
0.18 |
chr11_109472266_109472467 | 5.96 |
Slc16a6 |
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
322 |
0.75 |
chr11_60114297_60115906 | 5.96 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
129 |
0.95 |
chr19_4594162_4594488 | 5.94 |
Pcx |
pyruvate carboxylase |
21 |
0.96 |
chr3_89164654_89165398 | 5.91 |
Clk2 |
CDC-like kinase 2 |
47 |
0.92 |
chr10_85127631_85128502 | 5.88 |
Mterf2 |
mitochondrial transcription termination factor 2 |
39 |
0.97 |
chr15_96288532_96288689 | 5.88 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
1037 |
0.53 |
chr10_81092585_81092876 | 5.86 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
155 |
0.88 |
chr14_54517719_54518243 | 5.86 |
Prmt5 |
protein arginine N-methyltransferase 5 |
456 |
0.67 |
chr3_95893729_95894624 | 5.85 |
Aph1a |
aph1 homolog A, gamma secretase subunit |
121 |
0.9 |
chr2_156840246_156841082 | 5.84 |
Tgif2 |
TGFB-induced factor homeobox 2 |
358 |
0.63 |
chrX_103616321_103616657 | 5.84 |
Ftx |
Ftx transcript, Xist regulator (non-protein coding) |
346 |
0.76 |
chr1_178337652_178338055 | 5.83 |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
56 |
0.95 |
chr16_13216713_13216864 | 5.82 |
Mrtfb |
myocardin related transcription factor B |
39693 |
0.18 |
chr7_142658735_142659435 | 5.79 |
Igf2 |
insulin-like growth factor 2 |
404 |
0.55 |
chr5_33629059_33629461 | 5.79 |
Fam53a |
family with sequence similarity 53, member A |
198 |
0.8 |
chr10_82630023_82630438 | 5.78 |
Tdg |
thymine DNA glycosylase |
354 |
0.83 |
chr1_168312808_168312983 | 5.77 |
Gm37524 |
predicted gene, 37524 |
24776 |
0.22 |
chr19_44283591_44284731 | 5.77 |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
9513 |
0.11 |
chr14_26637559_26638269 | 5.77 |
Arf4 |
ADP-ribosylation factor 4 |
160 |
0.63 |
chr9_59486541_59487299 | 5.77 |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
302 |
0.87 |
chr2_180119334_180119886 | 5.76 |
Osbpl2 |
oxysterol binding protein-like 2 |
206 |
0.9 |
chr11_93885276_93885644 | 5.75 |
Utp18 |
UTP18 small subunit processome component |
306 |
0.57 |
chr11_101665033_101665892 | 5.75 |
Arl4d |
ADP-ribosylation factor-like 4D |
79 |
0.94 |
chr17_23803374_23803967 | 5.74 |
Srrm2 |
serine/arginine repetitive matrix 2 |
436 |
0.57 |
chr2_79254049_79254222 | 5.72 |
Itga4 |
integrin alpha 4 |
1291 |
0.53 |
chr2_154791776_154791939 | 5.72 |
Raly |
hnRNP-associated with lethal yellow |
142 |
0.8 |
chr11_75926900_75927103 | 5.72 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
1110 |
0.53 |
chr9_57644752_57646108 | 5.71 |
Csk |
c-src tyrosine kinase |
187 |
0.91 |
chr8_36283609_36283970 | 5.70 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
34273 |
0.16 |
chr10_80421820_80422012 | 5.69 |
Tcf3 |
transcription factor 3 |
56 |
0.94 |
chr4_10874128_10874685 | 5.68 |
2610301B20Rik |
RIKEN cDNA 2610301B20 gene |
92 |
0.79 |
chr12_32142869_32143111 | 5.68 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19288 |
0.17 |
chr5_139380266_139381195 | 5.68 |
Gpr146 |
G protein-coupled receptor 146 |
149 |
0.92 |
chr1_191063160_191063515 | 5.67 |
Nsl1 |
NSL1, MIS12 kinetochore complex component |
306 |
0.54 |
chr5_34573891_34574310 | 5.65 |
Mir7036b |
microRNA 7036b |
51 |
0.49 |
chr14_31001543_31001767 | 5.65 |
Spcs1 |
signal peptidase complex subunit 1 homolog (S. cerevisiae) |
11 |
0.49 |
chr15_27444875_27445166 | 5.64 |
Gm36899 |
predicted gene, 36899 |
18429 |
0.16 |
chr18_62179453_62180206 | 5.61 |
Adrb2 |
adrenergic receptor, beta 2 |
130 |
0.72 |
chr1_136345349_136346073 | 5.61 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
13 |
0.97 |
chr5_140597401_140597576 | 5.60 |
Gm43703 |
predicted gene 43703 |
9063 |
0.13 |
chr12_51828795_51830087 | 5.60 |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
95 |
0.97 |
chr10_26920587_26920754 | 5.59 |
Gm48084 |
predicted gene, 48084 |
29070 |
0.17 |
chr11_32543138_32543302 | 5.59 |
Stk10 |
serine/threonine kinase 10 |
9915 |
0.2 |
chr5_140606846_140607467 | 5.59 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
164 |
0.83 |
chr9_56951116_56951430 | 5.58 |
Snupn |
snurportin 1 |
395 |
0.75 |
chr7_25249061_25250506 | 5.58 |
Erf |
Ets2 repressor factor |
947 |
0.33 |
chr4_53155463_53155614 | 5.57 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
4357 |
0.25 |
chr3_96220445_96221400 | 5.56 |
H2ac20 |
H2A clustered histone 20 |
42 |
0.58 |
chr13_64179369_64179540 | 5.53 |
Habp4 |
hyaluronic acid binding protein 4 |
5049 |
0.13 |
chr10_26828769_26829098 | 5.53 |
Arhgap18 |
Rho GTPase activating protein 18 |
6331 |
0.25 |
chr7_140036275_140036472 | 5.52 |
Tubgcp2 |
tubulin, gamma complex associated protein 2 |
17 |
0.49 |
chr19_47067510_47068274 | 5.48 |
Taf5 |
TATA-box binding protein associated factor 5 |
146 |
0.92 |
chr2_162931701_162931928 | 5.47 |
Srsf6 |
serine and arginine-rich splicing factor 6 |
153 |
0.93 |
chr16_32002619_32003020 | 5.46 |
Senp5 |
SUMO/sentrin specific peptidase 5 |
344 |
0.75 |
chr14_70466532_70467176 | 5.46 |
Phyhip |
phytanoyl-CoA hydroxylase interacting protein |
8331 |
0.1 |
chr15_62712440_62713036 | 5.44 |
Gm24810 |
predicted gene, 24810 |
59734 |
0.14 |
chr11_108424530_108425250 | 5.41 |
Cep112 |
centrosomal protein 112 |
302 |
0.86 |
chr11_117204633_117204995 | 5.40 |
Septin9 |
septin 9 |
5153 |
0.19 |
chr6_146955907_146956238 | 5.40 |
1700034J05Rik |
RIKEN cDNA 1700034J05 gene |
1650 |
0.31 |
chr4_41087036_41087214 | 5.36 |
Aqp3 |
aquaporin 3 |
7323 |
0.12 |
chr14_53033253_53033591 | 5.34 |
Gm30214 |
predicted gene, 30214 |
6044 |
0.17 |
chr15_81729228_81729521 | 5.32 |
Rangap1 |
RAN GTPase activating protein 1 |
25 |
0.96 |
chr18_67641503_67641982 | 5.32 |
Psmg2 |
proteasome (prosome, macropain) assembly chaperone 2 |
134 |
0.79 |
chr15_52166263_52166617 | 5.31 |
Gm2387 |
predicted gene 2387 |
77132 |
0.09 |
chrX_12587282_12587870 | 5.31 |
Atp6ap2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
225 |
0.94 |
chr2_18997988_18998869 | 5.30 |
4930426L09Rik |
RIKEN cDNA 4930426L09 gene |
85 |
0.78 |
chr12_102744246_102744437 | 5.29 |
Tmem251 |
transmembrane protein 251 |
579 |
0.39 |
chr3_83039790_83039970 | 5.29 |
Fgb |
fibrinogen beta chain |
9983 |
0.14 |
chr7_103860925_103861255 | 5.29 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
7874 |
0.06 |
chr1_127755927_127756243 | 5.28 |
Acmsd |
amino carboxymuconate semialdehyde decarboxylase |
672 |
0.68 |
chr6_136857954_136858187 | 5.28 |
Art4 |
ADP-ribosyltransferase 4 |
337 |
0.77 |
chr1_9747811_9748033 | 5.26 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
34 |
0.88 |
chr2_131179660_131179917 | 5.25 |
Cenpb |
centromere protein B |
279 |
0.81 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.4 | GO:0042938 | dipeptide transport(GO:0042938) |
3.8 | 11.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
3.4 | 10.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
3.2 | 15.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
2.9 | 8.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
2.7 | 5.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.7 | 10.7 | GO:0050904 | diapedesis(GO:0050904) |
2.6 | 10.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.5 | 7.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
2.5 | 7.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
2.5 | 7.4 | GO:0036394 | amylase secretion(GO:0036394) |
2.3 | 9.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.3 | 4.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.3 | 9.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
2.3 | 6.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
2.3 | 6.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.3 | 6.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.3 | 9.0 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
2.2 | 6.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.2 | 11.0 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.1 | 6.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
2.1 | 8.5 | GO:0006848 | pyruvate transport(GO:0006848) |
2.1 | 6.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.1 | 6.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.1 | 6.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.1 | 12.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.0 | 6.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.0 | 8.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.0 | 6.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.0 | 6.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.0 | 5.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.0 | 7.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
2.0 | 2.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.9 | 3.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.9 | 7.7 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.9 | 1.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.9 | 5.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.9 | 5.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.9 | 5.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.9 | 7.5 | GO:0007296 | vitellogenesis(GO:0007296) |
1.9 | 15.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.9 | 7.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.8 | 5.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.8 | 1.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.8 | 5.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.8 | 5.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.8 | 1.8 | GO:1903416 | response to glycoside(GO:1903416) |
1.8 | 5.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.8 | 3.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.8 | 10.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.8 | 8.9 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.8 | 7.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.8 | 1.8 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.8 | 5.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.8 | 10.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.8 | 5.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.7 | 7.0 | GO:0070836 | caveola assembly(GO:0070836) |
1.7 | 5.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.7 | 5.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.7 | 5.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.7 | 6.8 | GO:0048478 | replication fork protection(GO:0048478) |
1.7 | 10.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.7 | 1.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.7 | 8.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.6 | 4.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.6 | 6.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.6 | 4.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.6 | 6.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.6 | 10.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.6 | 4.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.6 | 3.1 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.5 | 9.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
1.5 | 16.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
1.5 | 3.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.5 | 7.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.5 | 11.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.5 | 4.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.4 | 2.9 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.4 | 5.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.4 | 8.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.4 | 4.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.4 | 4.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.4 | 4.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.4 | 7.1 | GO:0080009 | mRNA methylation(GO:0080009) |
1.4 | 10.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.4 | 4.3 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
1.4 | 1.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.4 | 2.8 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.4 | 4.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.4 | 5.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.4 | 2.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.4 | 5.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.4 | 11.1 | GO:0032782 | bile acid secretion(GO:0032782) |
1.4 | 4.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.4 | 8.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.4 | 4.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.4 | 4.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.4 | 4.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.3 | 1.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.3 | 4.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.3 | 2.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.3 | 4.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.3 | 5.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.3 | 3.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.3 | 12.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.3 | 3.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.3 | 8.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.3 | 3.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 1.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.3 | 3.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.3 | 11.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.3 | 3.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.3 | 5.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.2 | 6.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.2 | 7.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.2 | 3.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.2 | 12.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.2 | 1.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
1.2 | 18.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.2 | 3.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.2 | 14.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.2 | 2.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.2 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
1.2 | 6.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.2 | 7.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.2 | 7.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.2 | 2.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.2 | 2.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.2 | 2.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.2 | 2.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.2 | 4.7 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.2 | 3.5 | GO:0019086 | late viral transcription(GO:0019086) |
1.2 | 10.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.2 | 5.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 4.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.2 | 3.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.2 | 6.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.2 | 2.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.1 | 4.6 | GO:0034214 | protein hexamerization(GO:0034214) |
1.1 | 2.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.1 | 10.2 | GO:0034063 | stress granule assembly(GO:0034063) |
1.1 | 3.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.1 | 3.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.1 | 4.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.1 | 2.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 7.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.1 | 7.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.1 | 4.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
1.1 | 1.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.1 | 2.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.1 | 1.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.1 | 3.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.1 | 2.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
1.1 | 3.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.1 | 6.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.1 | 2.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.1 | 2.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.1 | 3.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 3.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.1 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 1.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.1 | 4.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.1 | 3.2 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 4.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.1 | 4.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.0 | 7.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.0 | 4.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.0 | 2.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.0 | 2.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.0 | 6.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.0 | 3.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 3.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
1.0 | 2.1 | GO:1903147 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
1.0 | 11.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
1.0 | 1.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.0 | 10.2 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
1.0 | 5.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
1.0 | 4.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.0 | 21.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.0 | 5.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.0 | 3.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.0 | 4.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.0 | 3.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.0 | 5.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.0 | 4.0 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
1.0 | 1.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
1.0 | 2.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.0 | 6.9 | GO:1901660 | calcium ion export(GO:1901660) |
1.0 | 1.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.0 | 3.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.0 | 3.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.0 | 2.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 3.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.0 | 7.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.0 | 1.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.0 | 4.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.0 | 5.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.0 | 9.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.0 | 1.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.0 | 2.9 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
1.0 | 11.4 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.9 | 3.8 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.9 | 3.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 2.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 4.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.9 | 2.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.9 | 2.8 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.9 | 5.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.9 | 2.8 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.9 | 3.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.9 | 8.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.9 | 4.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 8.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.9 | 0.9 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.9 | 7.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 1.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.9 | 3.7 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.9 | 3.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 2.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.9 | 5.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.9 | 2.7 | GO:0040031 | snRNA modification(GO:0040031) |
0.9 | 7.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.9 | 3.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.9 | 7.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.9 | 4.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.9 | 7.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.9 | 6.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.9 | 2.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.9 | 3.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.9 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.9 | 7.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.9 | 4.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.9 | 4.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.9 | 3.5 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.9 | 1.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.9 | 1.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.9 | 3.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.9 | 3.4 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.9 | 2.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.9 | 1.7 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.9 | 10.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.9 | 0.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.9 | 2.6 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.9 | 0.9 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.9 | 6.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 0.9 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.9 | 11.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.9 | 1.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 4.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.8 | 2.5 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.8 | 8.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.8 | 4.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.8 | 10.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.8 | 8.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.8 | 5.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 6.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 2.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.8 | 0.8 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.8 | 4.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.8 | 3.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 0.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.8 | 3.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.8 | 3.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.8 | 9.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.8 | 3.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 2.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.8 | 1.6 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.8 | 1.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.8 | 1.6 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.8 | 13.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.8 | 3.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.8 | 0.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.8 | 4.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.8 | 4.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 2.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 1.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 3.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.8 | 3.2 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.8 | 11.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.8 | 2.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.8 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.8 | 11.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.8 | 3.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.8 | 0.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.8 | 6.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.8 | 9.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.8 | 3.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.8 | 3.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.8 | 2.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.8 | 2.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.8 | 6.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.8 | 3.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.8 | 2.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.8 | 3.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 6.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.8 | 0.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 2.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.8 | 6.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.8 | 7.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.8 | 3.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 2.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.8 | 0.8 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.8 | 1.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.8 | 0.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.8 | 3.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 6.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.7 | 2.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 2.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 5.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.7 | 2.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.7 | 3.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 0.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.7 | 3.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 1.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 1.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.7 | 2.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 3.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.7 | 2.9 | GO:1903333 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
0.7 | 2.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 3.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 3.6 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.7 | 2.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.7 | 1.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.7 | 2.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.7 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 2.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.7 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 2.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.7 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 2.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.7 | 4.9 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.7 | 2.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 2.8 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.7 | 5.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.7 | 1.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.7 | 2.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.7 | 5.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.7 | 2.8 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.7 | 2.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 0.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.7 | 3.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.7 | 0.7 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.7 | 6.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.7 | 17.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.7 | 3.5 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.7 | 0.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.7 | 4.8 | GO:0051231 | spindle elongation(GO:0051231) |
0.7 | 1.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.7 | 4.1 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.7 | 4.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.7 | 4.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.7 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 4.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 10.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 4.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.7 | 2.7 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.7 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.7 | 3.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 1.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 2.0 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 26.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.7 | 1.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 2.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.7 | 2.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 6.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.7 | 4.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.7 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 2.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.7 | 4.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.7 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.7 | 2.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 4.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.7 | 2.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.7 | 2.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 2.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.7 | 2.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.7 | 3.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.7 | 2.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.7 | 1.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 0.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.7 | 2.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 7.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.6 | 5.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.6 | 1.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.6 | 5.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 3.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.6 | 1.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 2.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.6 | 1.9 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.6 | 1.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 1.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 2.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 3.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 2.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 8.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 3.8 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.6 | 7.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.6 | 0.6 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.6 | 0.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 4.4 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.6 | 6.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.6 | 3.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.6 | 1.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.6 | 2.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 2.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.6 | 14.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 0.6 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.6 | 10.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 3.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.6 | 15.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.6 | 6.8 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 3.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 1.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.6 | 1.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 1.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.6 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.6 | 8.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 6.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.6 | 1.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 0.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.6 | 1.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 6.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 3.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 2.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.6 | 2.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 2.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.6 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 6.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.6 | 1.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 1.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 1.8 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.6 | 1.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.6 | 3.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 3.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 1.8 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.6 | 0.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.6 | 29.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.6 | 3.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 3.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 1.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 1.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 0.6 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.6 | 1.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.6 | 6.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 2.3 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.6 | 1.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.6 | 4.0 | GO:0032402 | melanosome transport(GO:0032402) |
0.6 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.6 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 9.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 1.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.6 | 0.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 1.7 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.6 | 5.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.6 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 2.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 1.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.6 | 2.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 2.2 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.6 | 11.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.6 | 2.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 13.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.6 | 4.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 7.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.5 | 10.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.5 | 2.7 | GO:0070627 | ferrous iron import(GO:0070627) |
0.5 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 1.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 5.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.5 | 2.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.5 | 2.7 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.5 | 2.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 3.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 0.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.5 | 1.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 2.1 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.5 | 1.6 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.5 | 1.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.5 | 1.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.5 | 3.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 1.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.5 | 1.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.5 | 2.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 1.0 | GO:2000664 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.5 | 0.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.5 | 2.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 1.5 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.5 | 2.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 1.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 1.5 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 3.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 2.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 2.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.5 | 1.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 9.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 1.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 2.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.5 | 2.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 1.5 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.5 | 1.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.5 | 2.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 2.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 0.5 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.5 | 3.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 2.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 0.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 13.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.5 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.5 | 2.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.5 | 0.5 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.5 | 1.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 1.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 2.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.5 | 2.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.5 | 2.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 7.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 2.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 0.5 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.5 | 3.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 2.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 2.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.5 | 1.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.5 | 2.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 9.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 1.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 2.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 1.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.5 | 1.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 0.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.5 | 2.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 2.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.5 | 1.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 2.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 1.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 2.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 3.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.5 | 1.4 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.5 | 1.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 0.5 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.5 | 1.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 3.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 1.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.5 | 0.9 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.5 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 6.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 1.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 1.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 2.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 4.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 0.5 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.5 | 2.8 | GO:0010225 | response to UV-C(GO:0010225) |
0.5 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.5 | 0.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 0.9 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.5 | 0.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.5 | 5.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.5 | 2.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 3.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 4.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 0.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 0.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.5 | 1.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 12.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.5 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 1.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.5 | 1.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.5 | 4.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 2.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 1.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 2.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 | 8.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 1.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 0.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.4 | 1.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 3.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 3.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 3.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.4 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 1.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.4 | 2.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 3.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 3.9 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.4 | 4.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 2.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 1.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 1.3 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 6.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 2.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.4 | 0.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 6.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 0.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 3.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.4 | 1.7 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.4 | 2.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 2.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.4 | 2.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 4.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.4 | 2.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 0.4 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 0.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.4 | 1.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 0.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 0.8 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.4 | 0.8 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 1.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 1.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 1.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 7.0 | GO:0007569 | cell aging(GO:0007569) |
0.4 | 3.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 0.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.4 | 4.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 0.8 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 6.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 0.8 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.4 | 2.4 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.4 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.4 | 5.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 1.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 5.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.4 | 0.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 4.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 3.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 1.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.4 | 4.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.4 | 8.2 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 2.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 7.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 9.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 0.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 0.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 3.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 0.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 3.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 1.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.4 | 0.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.4 | 0.4 | GO:0061724 | lipophagy(GO:0061724) |
0.4 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 1.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.4 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.5 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.4 | 0.4 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 4.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 1.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 1.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 6.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.5 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.4 | 1.5 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.4 | 2.6 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.4 | 3.3 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.4 | 4.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 6.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 2.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 15.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.4 | 0.4 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 1.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.4 | 3.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.4 | 2.2 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.4 | 9.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 2.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.4 | 2.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 0.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.4 | 2.1 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 1.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 0.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 1.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 1.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 1.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 11.8 | GO:0051298 | centrosome duplication(GO:0051298) |
0.3 | 1.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.3 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 2.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.3 | 0.3 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 2.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 1.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.3 | 11.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 1.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 1.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 12.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 1.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 1.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 2.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 1.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 1.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 0.6 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 1.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 1.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 0.3 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 1.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 5.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.3 | 1.6 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.3 | 4.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.3 | 2.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 2.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 0.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 8.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.3 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.3 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 3.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.3 | 0.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.3 | 8.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 2.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.3 | 39.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 1.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.3 | 3.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 2.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 1.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 4.5 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.3 | 0.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 6.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 2.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.2 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 0.6 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 1.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.9 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 1.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 1.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 3.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.3 | 1.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.8 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 0.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 13.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 3.6 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 1.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 2.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 1.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.3 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.3 | 2.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 3.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 1.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 4.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 0.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 0.5 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.8 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 1.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 3.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 1.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 2.3 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.3 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 3.1 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 2.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 2.5 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.3 | 1.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.5 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 1.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 4.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 1.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 1.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 1.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.2 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 2.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 4.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.7 | GO:0042511 | tyrosine phosphorylation of Stat1 protein(GO:0042508) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.2 | 0.5 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.5 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 3.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 2.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 1.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 3.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.6 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 0.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 5.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 2.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 1.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.9 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 4.3 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 2.0 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.2 | 0.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 2.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 4.4 | GO:0009651 | response to salt stress(GO:0009651) |
0.2 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 1.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 1.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 1.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 1.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.6 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.2 | 9.3 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 1.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 1.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.0 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 1.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 5.6 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 2.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 4.3 | GO:0051297 | centrosome organization(GO:0051297) |
0.2 | 1.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 1.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.8 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 5.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
0.2 | 0.2 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 1.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.2 | GO:0071724 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 4.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.4 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.4 | GO:0051029 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.2 | 0.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 0.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.9 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.7 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.2 | GO:0070474 | regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 0.9 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 4.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 2.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.2 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 1.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 1.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 3.9 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 2.4 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.5 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.2 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 1.9 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.2 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 4.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 2.6 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 2.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 1.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 1.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.6 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.5 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 3.2 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 1.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.9 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.4 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 3.8 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 2.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 2.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 6.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.6 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 1.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 1.1 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 1.0 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.5 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 6.3 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.4 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.5 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.1 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 1.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 1.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 1.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 2.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 2.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 3.1 | GO:0006364 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 1.7 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 2.1 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 1.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.1 | GO:2000053 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.4 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.1 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.1 | 3.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.8 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 2.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 2.1 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 2.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 3.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.3 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 3.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 1.6 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 1.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.1 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 1.0 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.1 | 0.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.2 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.1 | 0.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.5 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:1904396 | regulation of neuromuscular junction development(GO:1904396) |
0.1 | 0.8 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.1 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.6 | GO:0002221 | pattern recognition receptor signaling pathway(GO:0002221) |
0.1 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.1 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.1 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.1 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.0 | 0.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.3 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.1 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 2.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0007128 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) regulation of membrane invagination(GO:1905153) |
0.0 | 0.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.1 | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0048382 | mesendoderm development(GO:0048382) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.0 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.0 | GO:2000851 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.0 | 0.0 | GO:0002218 | activation of innate immune response(GO:0002218) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 1.2 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.0 | 0.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 1.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0032606 | type I interferon production(GO:0032606) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0033685 | regulation of luteinizing hormone secretion(GO:0033684) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.6 | 7.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 6.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.0 | 8.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.0 | 5.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.8 | 1.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
1.7 | 13.7 | GO:0001650 | fibrillar center(GO:0001650) |
1.7 | 6.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.7 | 5.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.7 | 8.4 | GO:0061617 | MICOS complex(GO:0061617) |
1.7 | 6.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.6 | 12.8 | GO:0001939 | female pronucleus(GO:0001939) |
1.5 | 6.1 | GO:0005642 | annulate lamellae(GO:0005642) |
1.5 | 6.1 | GO:0005955 | calcineurin complex(GO:0005955) |
1.5 | 5.9 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.5 | 8.9 | GO:0000812 | Swr1 complex(GO:0000812) |
1.5 | 5.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.4 | 8.6 | GO:0005818 | aster(GO:0005818) |
1.4 | 4.3 | GO:0035838 | growing cell tip(GO:0035838) |
1.4 | 4.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.4 | 1.4 | GO:0061574 | ASAP complex(GO:0061574) |
1.4 | 17.9 | GO:0030914 | STAGA complex(GO:0030914) |
1.4 | 4.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.4 | 4.1 | GO:0005687 | U4 snRNP(GO:0005687) |
1.4 | 8.2 | GO:0001739 | sex chromatin(GO:0001739) |
1.3 | 2.7 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
1.3 | 5.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.3 | 5.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.3 | 7.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 5.2 | GO:0045298 | tubulin complex(GO:0045298) |
1.3 | 5.2 | GO:1990246 | uniplex complex(GO:1990246) |
1.3 | 2.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.3 | 3.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.3 | 17.6 | GO:0000974 | Prp19 complex(GO:0000974) |
1.3 | 8.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.2 | 3.7 | GO:0031417 | NatC complex(GO:0031417) |
1.2 | 2.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.2 | 15.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.2 | 10.8 | GO:0005869 | dynactin complex(GO:0005869) |
1.2 | 3.6 | GO:0070552 | BRISC complex(GO:0070552) |
1.2 | 8.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.2 | 3.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.2 | 3.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.2 | 8.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.1 | 4.6 | GO:0042825 | TAP complex(GO:0042825) |
1.1 | 3.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.1 | 6.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.1 | 12.1 | GO:0032797 | SMN complex(GO:0032797) |
1.1 | 4.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.1 | 1.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
1.1 | 4.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 3.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.0 | 5.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.0 | 5.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 3.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.0 | 4.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.0 | 4.0 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 5.0 | GO:0008091 | spectrin(GO:0008091) |
1.0 | 2.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 4.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 3.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 13.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.0 | 8.6 | GO:0034709 | methylosome(GO:0034709) |
1.0 | 1.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.9 | 6.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.9 | 13.9 | GO:0000786 | nucleosome(GO:0000786) |
0.9 | 3.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.9 | 3.7 | GO:0035363 | histone locus body(GO:0035363) |
0.9 | 3.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.9 | 4.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.9 | 6.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.9 | 10.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.9 | 6.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.9 | 2.7 | GO:0031523 | Myb complex(GO:0031523) |
0.9 | 1.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.9 | 2.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 18.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 11.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.8 | 3.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 2.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 5.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 7.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.8 | 2.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.8 | 6.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 2.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 7.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 7.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.8 | 5.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.8 | 13.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.8 | 3.2 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 7.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.8 | 7.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.8 | 1.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.8 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 8.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 2.3 | GO:0036396 | MIS complex(GO:0036396) |
0.8 | 3.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 4.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 1.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 4.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.8 | 3.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 2.2 | GO:0030689 | Noc complex(GO:0030689) |
0.7 | 2.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 5.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.7 | 6.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 8.0 | GO:0032039 | integrator complex(GO:0032039) |
0.7 | 4.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 2.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 2.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 2.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.7 | 37.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.7 | 2.1 | GO:0000811 | GINS complex(GO:0000811) |
0.7 | 23.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.7 | 2.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 2.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 5.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 4.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 7.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.7 | 10.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 2.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 4.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.7 | 2.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 19.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 5.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.7 | 4.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.7 | 6.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 2.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.7 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.7 | 33.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.7 | 2.6 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 9.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.7 | 6.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 2.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 3.9 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 4.5 | GO:0045120 | pronucleus(GO:0045120) |
0.6 | 36.9 | GO:0000776 | kinetochore(GO:0000776) |
0.6 | 2.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 1.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.6 | 5.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.6 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 3.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 16.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 41.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 10.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 4.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 1.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.6 | 9.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 13.0 | GO:0015030 | Cajal body(GO:0015030) |
0.6 | 4.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 1.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 9.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 1.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.6 | 1.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 10.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 3.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 4.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 4.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.6 | 3.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.6 | 2.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 14.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 4.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.6 | 2.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.6 | 1.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 4.5 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 23.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 24.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.6 | 7.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 1.1 | GO:0044393 | microspike(GO:0044393) |
0.5 | 11.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.5 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 23.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 26.4 | GO:0016605 | PML body(GO:0016605) |
0.5 | 1.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 0.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.5 | 2.1 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.5 | 2.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 5.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 24.4 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 37.6 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.5 | 4.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.5 | 2.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 4.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 2.5 | GO:0097433 | dense body(GO:0097433) |
0.5 | 5.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.5 | 5.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 3.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 7.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 64.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 1.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 22.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 14.8 | GO:0005844 | polysome(GO:0005844) |
0.5 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 1.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.5 | 1.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.5 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 3.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 1.8 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.5 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 7.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 5.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 1.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 2.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 16.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 1.8 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 0.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 7.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 2.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 1.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 2.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 8.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 4.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 5.8 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 0.8 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 40.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 1.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 0.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 2.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 4.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 15.7 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 5.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 5.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 18.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 4.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 3.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 13.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.4 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
0.4 | 1.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 21.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 22.2 | GO:0016604 | nuclear body(GO:0016604) |
0.3 | 8.0 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 18.6 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 1.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 3.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 8.8 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 5.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 103.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 18.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.3 | 8.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 1.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.6 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 7.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 4.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 4.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 2.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 4.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 0.3 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.3 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 3.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 8.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 13.0 | GO:0030496 | midbody(GO:0030496) |
0.3 | 4.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 2.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 4.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 0.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.3 | 1.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 24.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 3.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 102.3 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 2.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 2.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.3 | 5.4 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 10.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 1.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 8.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 4.5 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.2 | 2.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 3.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.4 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 1.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 5.7 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 2.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 3.5 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 176.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.5 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.1 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 17.5 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 2.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 6.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 2.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.3 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle A(GO:0030991) |
0.2 | 0.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 2.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 3.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 3.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 98.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 3.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 9.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.5 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 1.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 4.6 | GO:0031975 | envelope(GO:0031975) |
0.1 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.1 | 14.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 3.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 9.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 2.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 5.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 4.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.5 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.2 | GO:0098687 | chromosomal region(GO:0098687) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 1.3 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 45.9 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0005795 | Golgi stack(GO:0005795) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.1 | 3.1 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
3.0 | 8.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.9 | 8.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.8 | 8.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.8 | 11.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
2.7 | 10.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.4 | 7.2 | GO:0050693 | LBD domain binding(GO:0050693) |
2.4 | 2.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.3 | 13.8 | GO:0004064 | arylesterase activity(GO:0004064) |
2.2 | 6.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.0 | 6.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.0 | 6.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.0 | 6.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
2.0 | 6.0 | GO:0050692 | DBD domain binding(GO:0050692) |
2.0 | 15.8 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.0 | 7.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.0 | 5.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.9 | 5.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.9 | 5.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.9 | 5.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.9 | 5.6 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.9 | 7.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 7.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.8 | 5.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.8 | 5.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.8 | 7.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.7 | 7.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.7 | 6.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.7 | 6.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.7 | 6.7 | GO:0009374 | biotin binding(GO:0009374) |
1.6 | 6.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.6 | 8.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.6 | 4.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.5 | 13.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.5 | 6.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.5 | 3.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.5 | 7.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.5 | 4.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.4 | 5.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.4 | 5.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.4 | 5.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.4 | 4.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.4 | 5.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.4 | 7.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.4 | 6.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 4.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.4 | 4.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.3 | 1.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 10.6 | GO:0034046 | poly(G) binding(GO:0034046) |
1.3 | 7.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.3 | 3.9 | GO:0004359 | glutaminase activity(GO:0004359) |
1.3 | 1.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.3 | 3.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.3 | 5.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.3 | 6.3 | GO:0070728 | leucine binding(GO:0070728) |
1.3 | 3.8 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.3 | 3.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.2 | 6.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.2 | 3.7 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 1.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 3.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.2 | 3.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 3.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.2 | 3.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.2 | 9.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.2 | 25.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.2 | 8.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.2 | 6.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.2 | 9.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
1.2 | 3.6 | GO:0000339 | RNA cap binding(GO:0000339) |
1.2 | 3.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.2 | 3.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.2 | 5.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.2 | 3.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.2 | 3.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.2 | 36.2 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.2 | 4.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.2 | 3.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.2 | 3.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.2 | 3.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.1 | 4.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.1 | 2.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 11.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.1 | 2.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.1 | 3.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.1 | 2.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.1 | 2.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.1 | 8.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.1 | 16.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.1 | 4.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.1 | 4.3 | GO:0038132 | neuregulin binding(GO:0038132) |
1.1 | 5.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
1.1 | 8.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.1 | 4.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 3.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 9.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.1 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
1.1 | 1.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.0 | 7.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.0 | 20.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.0 | 46.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.0 | 5.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.0 | 1.0 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.0 | 4.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.0 | 3.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 11.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.0 | 7.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.0 | 3.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.0 | 3.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.0 | 1.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.0 | 5.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 2.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.0 | 10.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 6.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.0 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.0 | 2.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.0 | 1.9 | GO:0030519 | snoRNP binding(GO:0030519) |
1.0 | 3.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.0 | 4.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.0 | 9.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 3.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.9 | 3.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.9 | 2.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.9 | 2.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.9 | 4.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 8.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.9 | 3.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.9 | 0.9 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.9 | 4.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.9 | 1.8 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.9 | 1.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.9 | 7.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.9 | 7.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 3.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.8 | 5.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.8 | 3.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.8 | 1.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 4.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.8 | 5.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 4.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 13.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.8 | 7.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 5.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.8 | 2.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.8 | 9.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 7.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 2.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.8 | 19.5 | GO:0045502 | dynein binding(GO:0045502) |
0.8 | 2.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 3.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 8.1 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.8 | 2.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.8 | 2.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.8 | 3.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.8 | 3.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 2.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 6.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.8 | 3.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.8 | 2.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.8 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 9.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 9.1 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.8 | 2.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 3.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.8 | 2.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 3.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 3.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.7 | 2.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 8.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.7 | 11.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.7 | 6.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.7 | 2.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.7 | 2.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 3.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.7 | 2.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.7 | 4.4 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.7 | 10.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.7 | 5.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 10.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.7 | 2.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 4.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.7 | 3.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 4.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 3.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 5.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.7 | 2.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 6.2 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.7 | 17.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 4.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 3.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.7 | 2.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 2.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 2.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.7 | 2.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 2.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 5.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.7 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 9.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 5.3 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.7 | 4.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 3.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.7 | 2.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 2.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 3.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.6 | 8.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 17.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 1.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.6 | 0.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 1.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.6 | 5.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.6 | 3.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 1.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 3.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 3.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 3.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 10.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 3.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.6 | 12.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 5.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 1.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 6.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 6.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.6 | 1.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 4.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 15.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.6 | 3.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 3.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 25.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 1.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 3.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 4.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 3.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 4.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.6 | 8.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.6 | 5.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.6 | 9.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 1.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 3.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 3.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.6 | 5.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 2.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 1.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 9.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 4.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 4.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 1.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 5.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.5 | 16.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 1.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.5 | 1.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 3.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 6.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.5 | 5.8 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.5 | 1.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 7.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 4.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 1.0 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 2.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 1.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 1.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 1.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 3.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 2.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 4.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.5 | 3.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 5.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 2.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 1.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 5.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 7.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 4.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 2.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 5.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 5.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 1.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 2.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 3.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 1.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 1.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 3.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 0.9 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 4.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 10.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 4.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 5.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 2.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 5.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.5 | 6.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 6.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 1.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 1.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.5 | 11.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.5 | 1.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 7.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 17.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 1.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 17.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 3.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 2.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 2.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 1.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 13.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 5.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 10.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 3.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 4.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 12.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 5.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 2.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 17.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 29.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 4.1 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 2.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 4.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 76.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 8.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 0.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 2.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 2.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 2.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 3.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 9.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 2.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 5.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 6.6 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 3.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.9 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 7.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.4 | 0.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 6.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 4.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 4.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 1.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 3.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 0.4 | GO:0070990 | snRNP binding(GO:0070990) |
0.4 | 11.7 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 3.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 7.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 1.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 5.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 8.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 8.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 4.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 4.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.3 | 7.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 6.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 5.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 58.2 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.3 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 2.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 2.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 3.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 1.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.3 | 1.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 2.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 11.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 6.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 4.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 1.2 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 1.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 14.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 1.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 5.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 2.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 2.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 6.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 2.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 4.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 1.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 2.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 31.7 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 1.7 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 0.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 1.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 2.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 1.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 1.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 11.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 16.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.2 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 1.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 1.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 8.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 5.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 0.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 3.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 4.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 3.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 19.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 6.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 3.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 11.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 5.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 1.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 111.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 2.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 4.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 3.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.4 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 2.4 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 6.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.5 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 2.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 7.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.5 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 2.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 5.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 3.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 3.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.3 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 1.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 1.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 37.3 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 3.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.4 | GO:0016886 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 3.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 1.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.4 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 2.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 11.6 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.9 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 7.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 14.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 5.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 3.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 6.0 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 7.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 2.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 1.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 1.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0015114 | sodium:phosphate symporter activity(GO:0005436) phosphate ion transmembrane transporter activity(GO:0015114) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0034936 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.6 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0018590 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.0 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0018498 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 26.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.8 | 14.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.2 | 11.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.2 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.1 | 18.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.1 | 31.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.0 | 6.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 35.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.0 | 32.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.0 | 30.6 | PID FOXO PATHWAY | FoxO family signaling |
1.0 | 2.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 18.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.0 | 7.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 16.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 49.5 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 13.7 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 2.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.8 | 31.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 16.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 2.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 36.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 2.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 5.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 19.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.8 | 6.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 14.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.7 | 25.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 18.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 2.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.7 | 9.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 6.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 6.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 13.9 | PID ATM PATHWAY | ATM pathway |
0.6 | 11.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 6.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 5.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 15.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 4.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 17.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 15.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 6.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 9.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 3.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 4.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 1.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 16.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 23.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 7.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 9.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 5.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 3.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 4.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 9.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 3.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 6.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 2.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 21.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 8.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 16.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 5.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 2.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 5.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 5.4 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 7.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 8.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 10.1 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 3.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 5.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 6.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 5.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 2.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 5.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 4.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 13.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 4.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 3.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 6.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
3.6 | 3.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.5 | 2.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
2.4 | 12.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.2 | 2.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
1.7 | 15.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.4 | 4.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.4 | 24.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.4 | 21.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.3 | 19.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 20.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.3 | 10.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.3 | 11.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.2 | 12.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 12.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 15.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.1 | 37.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.1 | 9.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 31.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.1 | 13.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 19.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.1 | 14.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 28.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.1 | 10.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.0 | 2.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 11.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 44.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.0 | 14.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 14.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 18.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 6.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.9 | 5.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.9 | 42.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 7.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.9 | 2.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.9 | 13.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 19.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 17.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 1.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.8 | 5.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.8 | 16.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.8 | 7.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.8 | 11.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.8 | 9.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.8 | 8.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.8 | 12.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 14.3 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.8 | 3.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.8 | 10.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.8 | 8.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.8 | 8.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.8 | 3.0 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.7 | 10.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 8.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 20.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 5.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 2.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 58.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.7 | 6.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 36.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 6.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 4.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 5.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 3.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.6 | 3.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 9.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.6 | 5.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 28.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 1.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.6 | 6.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.6 | 11.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 3.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 12.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 6.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 5.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 6.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 13.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.5 | 10.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 24.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.5 | 8.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 3.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 5.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 3.6 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.5 | 3.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 7.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 14.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 10.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.5 | 9.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 4.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 12.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.5 | 3.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 0.9 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.5 | 1.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 4.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 4.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 4.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 3.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 3.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 1.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 11.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 3.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 5.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 6.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 3.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 67.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 7.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 6.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 4.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 2.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 6.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 8.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 1.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 2.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 0.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 3.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 4.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 4.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 4.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 2.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 6.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 8.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 3.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 2.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 4.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 4.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 3.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 1.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 4.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 1.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 6.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 3.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 3.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 9.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 3.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 2.4 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.3 | 7.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 11.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 3.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 5.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 3.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 3.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 5.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 8.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 11.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 5.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 0.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 4.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 3.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 2.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 6.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |